Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study.
An ZY, Wu YJ, Hou Y, Mei H, Nong WX, Li WQ, Zhou H, Feng R, Shen JP, Peng J, Zhou H, Liu Y, Song YP, Yang LH, Fang MY, Li JY, Cheng YF, Liu P, Xu YJ, Wang Z, Luo Y, Cai Z, Liu H, Wang JW, Li J, Zhang X, Sun ZM, Zhu XY, Wang X, Fu R, Huang L, Wang SY, Yang TH, Su LP, Ma LM, Chen XQ, Liu DH, Yao HX, Feng J, Zhang HY, Jiang M, Zhou ZP, Wang WS, Shen XL, Baima Y, Li YY, Wang QF, Huang QS, Fu HX, Zhu XL, He Y, Jiang Q, Jiang H, Lu J, Zhao XY, Chang YJ, Wu T, Pan YZ, Qiu L, Gao D, Jin AR, Li W, Gao SJ, Zhang L, Hou M, Huang XJ, Zhang XH; National Cooperative ITP Working Group. An ZY, et al. Among authors: xu yj. Sci Bull (Beijing). 2023 Sep 30;68(18):2106-2114. doi: 10.1016/j.scib.2023.08.001. Epub 2023 Aug 3. Sci Bull (Beijing). 2023. PMID: 37599175 Free article.
Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center study.
Huo MR, Xu YJ, Zhai SZ, Lv M, Wang Y, Cao LQ, Xu LP, Zhang XH, Chen H, Chen YH, Wang FR, Han W, Sun YQ, Yan CH, Tang FF, Mo XD, Zhao MF, Liu KY, Huang XJ, Chang YJ. Huo MR, et al. Among authors: xu yj, xu lp. Hum Immunol. 2018 Sep;79(9):672-677. doi: 10.1016/j.humimm.2018.06.003. Epub 2018 Jun 8. Hum Immunol. 2018. PMID: 29890181 Free article.
Comparison of the clinical outcomes of hematologic malignancies after myeloablative haploidentical transplantation with G-CSF/ATG and posttransplant cyclophosphamide: results from the Chinese Bone Marrow Transplantation Registry Group (CBMTRG).
Tang F, Xu Y, Chen H, Xu L, Zhang X, Wang Y, Liu Q, Wu D, Huang X. Tang F, et al. Sci China Life Sci. 2020 Apr;63(4):571-581. doi: 10.1007/s11427-019-9594-7. Epub 2019 Aug 14. Sci China Life Sci. 2020. PMID: 31420852
Haploidentical hematopoietic cell transplantation for severe acquired aplastic anemia: a case-control study of post-transplant cyclophosphamide included regimen vs. anti-thymocyte globulin & colony-stimulating factor-based regimen.
Xu L, Fu B, Wang W, Xu Y, Wu D, Wang S, Liu Q, Xia L, Gao S, Jiang M, Wang J, Zhang X, Bai H, Chen H, Li C, Huang X. Xu L, et al. Sci China Life Sci. 2020 Jun;63(6):940-942. doi: 10.1007/s11427-019-9585-x. Epub 2019 Aug 14. Sci China Life Sci. 2020. PMID: 31428917 No abstract available.
Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.
Xuan L, Wang Y, Huang F, Fan Z, Xu Y, Sun J, Xu N, Deng L, Li X, Liang X, Luo X, Shi P, Liu H, Wang Z, Jiang L, Yu C, Zhou X, Lin R, Chen Y, Tu S, Huang X, Liu Q. Xuan L, et al. Lancet Oncol. 2020 Sep;21(9):1201-1212. doi: 10.1016/S1470-2045(20)30455-1. Epub 2020 Aug 10. Lancet Oncol. 2020. PMID: 32791048 Clinical Trial.
2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy.
Zhang X, Chen F, Chen X, Cheng Y, Fang M, Feng J, Fu H, Gao H, Han Y, He A, Hou M, Hu Y, Huang R, Huang W, Jing Z, Kong P, Liang A, Liang M, Liu D, Liu J, Liu L, Liu X, Ma L, Mei H, Ni H, Niu T, Peng J, Qiao J, Ren J, Song Y, Tang LV, Tong T, Wang S, Wang X, Wang Z, Wei H, Wu D, Wu G, Xu C, Xu X, Xu Y, Yang L, Yang R, Yang T, Yin C, Yu L, Zhang G, Zhang L, Zhang L, Zhang X, Zhao W, Zhao Y, Zhou D, Zhou H, Zhou Z, Zhu T, Wang J, Huang X. Zhang X, et al. Chin Med J (Engl). 2022 Apr 20;135(8):887-889. doi: 10.1097/CM9.0000000000002043. Chin Med J (Engl). 2022. PMID: 35730369 Free PMC article. No abstract available.
Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients.
Cheng T, Chen Y, Liu Y, Ma X, Zeng C, Chen X, Wang S, Xu Y. Cheng T, et al. Front Oncol. 2022 Jul 14;12:922120. doi: 10.3389/fonc.2022.922120. eCollection 2022. Front Oncol. 2022. PMID: 35912178 Free PMC article.
Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial.
Xu X, Fan Z, Wang Y, Huang F, Xu Y, Sun J, Xu N, Deng L, Li X, Liang X, Luo X, Shi P, Liu H, Chen Y, Tu S, Huang X, Liu Q, Xuan L. Xu X, et al. BMC Med. 2022 Sep 2;20(1):282. doi: 10.1186/s12916-022-02479-x. BMC Med. 2022. PMID: 36050712 Free PMC article. Clinical Trial.
Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China.
Liu W, Ji J, Zou D, Cao Y, Xu Y, Zhou J, Gao S, Wang F, Chen W, Du J, Zhou H, Zhou F, Shi J, Zhang X, Yang J, Jing H, Jiang Z, Liu H, Li C, Peng H, Jiang S, Wei X, He P, Liu Y, Yang H, Li Z, Huang X, Liu L, Shen L, Liu C, Song Y, Qiu L, Wang X, Ma J, Zhu J. Liu W, et al. Bone Marrow Transplant. 2023 Mar;58(3):349-352. doi: 10.1038/s41409-022-01899-w. Epub 2022 Dec 17. Bone Marrow Transplant. 2023. PMID: 36528754 No abstract available.
1,374 results